Ordinary Rebalance | Solactive Global Genomics Immunology and Medical Revolution Index | Effective Date 1st December 2023
In the ordinary rebalance, the following composition will be implemented effective open 01.12.2023:
| 10X GENOMICS INC |
| ABBVIE INC |
| AGILENT TECHNOLOGIES INC |
| ALNYLAM PHARMACEUTICALS INC |
| AMGEN INC |
| ASTRAZENECA PLC |
| AXSOME THERAPEUTICS INC |
| BEAM THERAPEUTICS INC |
| BECTON DICKINSON AND CO |
| BIO-TECHNE CORP |
| BIOGEN INC |
| BIONTECH SE |
| BRISTOL-MYERS SQUIBB CO |
| CRISPR THERAPEUTICS AG |
| EDITAS MEDICINE INC |
| ELI LILLY & CO |
| EXACT SCIENCES CORP |
| EXELIXIS INC |
| GENMAB A/S |
| GENSCRIPT BIOTECH CORP |
| GILEAD SCIENCES INC |
| GUARDANT HEALTH INC |
| ILLUMINA INC |
| INCYTE CORP |
| INNOVENT BIOLOGICS INC |
| INTELLIA THERAPEUTICS INC |
| JAZZ PHARMACEUTICALS PLC |
| JOHNSON & JOHNSON |
| LEGEND BIOTECH CORP |
| LONZA GROUP AG |
| MODERNA INC |
| NATERA INC |
| NOVARTIS AG |
| PACIFIC BIOSCIENCES OF CALIFORNIA INC |
| PFIZER INC |
| PTC THERAPEUTICS INC |
| QIAGEN NV |
| REGENERON PHARMACEUTICALS |
| ROCHE HOLDING AG |
| SAMSUNG BIOLOGICS CO LTD |
| SANOFI SA |
| SAREPTA THERAPEUTICS INC |
| SEAGEN INC |
| TG THERAPEUTICS INC |
| THERMO FISHER SCIENTIFIC INC |
| TWIST BIOSCIENCE CORP |
| ULTRAGENYX PHARMACEUTICAL INC |
| VERACYTE INC |
| VERTEX PHARMACEUTICALS INC |
| VERVE THERAPEUTICS INC |